Refreshing results…
Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial
UploadNeoadjuvant Selective RET Inhibitor for Medullary Thyroid Cancer: A Case Series
UploadEGFR and HER2 exon 20 insertions in solid tumours: from biology to treatment
Download from www.nature.comMissing publications? Search for publications with a matching author name.